Vacara AB is developing a focused pipeline of antigen-specific therapies and diagnostic solutions to improve treatment and early detection of immune-mediated diseases. These programs build on Vacara’s translational immunology expertise and are available for partnership.
Antigen-Specific Tolerance Vaccine
A peptide-based immunotherapy designed to restore immune tolerance by targeting disease-relevant antigens. This approach aims to provide durable disease modification without broad immunosuppression.
Novel Diagnostic Markers
A multiplex approach for detecting disease-associated autoantibodies, supporting earlier diagnosis, patient stratification, and disease monitoring in autoimmune conditions.
Partner With Us
Vacara is seeking partners for co-development, licensing, and clinical translation of its pipeline programs. → Contact us for discussion
